mepa8 Get alerts

National EMS data show prehospital buprenorphine grew from 33 to 1,574 encounters a year

Most patients had documented improvement after the drug, but only 16% of 9-1-1 buprenorphine encounters ended with EMS transport to a hospital.

Mepa8 headline card: National EMS data show prehospital buprenorphine grew from 33 to 1,574 encounters a year

Key takeaways

  • A cross-sectional study in The Western Journal of Emergency Medicine found 2,180 EMS encounters with buprenorphine administration in 2020-2023 national data, up from 33 in 2020 to 1,574 in 2023.
  • Paramedic crews handled 53% of the encounters and ALS community paramedics 46%; 72% took place in urban areas.
  • The most common initial dose was 8 mg (45%), followed by 16 mg (36%) and 24 mg (7%).
  • Documented improvement followed 80% of administrations, and four patients (0.2%) were documented as worse.
  • For crews: only 7% of 9-1-1 buprenorphine encounters had naloxone documented before the buprenorphine dose, and 16% of 9-1-1 encounters ended in EMS transport.

A cross-sectional study published November 13, 2026, in The Western Journal of Emergency Medicine reports that EMS administration of buprenorphine in the United States rose from 33 encounters in 2020 to 1,574 encounters in 2023 [1].

The authors, Chandran, Weiner, Goldberg, Holstein, Hayes and Cash, drew on the 2020-2023 National EMS Information System Public Release Research datasets. Out of 167,221,959 EMS encounters with patient contact, they identified 2,180 in which buprenorphine was given [1].

The abstract describes the backdrop. Starting buprenorphine lowers mortality in people with opioid use disorder, but patients who refuse transport after an overdose may never reach treatment. Prehospital buprenorphine pilot programs began in 2019 to close that gap. The authors wrote that "few studies have looked at these programs nationally" [1].

What the records show

The primary outcome was the trend in prehospital buprenorphine use. The team measured quarterly rates and applied joinpoint regression to find inflection points. Patient demographics and encounter characteristics were the secondary outcome, reported with descriptive statistics [1].

The joinpoint analysis found a break in quarter 2 of 2022. Before that, from 2020 through the first quarter of 2022, administrations grew by about 1 per quarter (95% CI, -1 to +3). After it, the slope rose to 54 administrations per quarter (95% CI, 20-89) [1].

Patients were 62% male (n = 1,349) with a mean age of 37 years (SD 10). About half of administrations, 52% (n = 1,125), happened on 9-1-1 responses. The South Atlantic region had the highest rate, at 4 administrations per 100,000 encounters, and 72% of encounters (n = 1,572) were in urban areas [1].

Nearly every crew was operating at the advanced life support level. Paramedic crews accounted for 53% (n = 1,155) and ALS community paramedic crews for 46% (n = 1,008) [1].

Initial buprenorphine doseShare of encountersCount
8 mg45%973
16 mg36%786
24 mg7%160

Documented improvement followed 80% of administrations (n = 1,746). Four patients (0.2%) were documented as worse afterward [1].

Among 9-1-1 encounters, 16% (n = 180) ended with EMS transport to a hospital. Naloxone was documented before the buprenorphine dose in 7% (n = 82) of 9-1-1 buprenorphine encounters [1].

Why it matters for EMS

The data describe a practice that has moved from a handful of pilot sites to more than a thousand encounters a year, concentrated on paramedic and community paramedic units. The authors concluded that prehospital buprenorphine "may be considered by EMS agencies" as a way to prevent deaths from later opioid use and to link patients to treatment [1].

Two findings bear directly on how these encounters unfold in the field. Most 9-1-1 buprenorphine encounters did not end in EMS transport, which fits the stated purpose of reaching patients who decline the hospital. And the low rate of documented prior naloxone suggests that, in the records, buprenorphine was often not given as a follow-on to an acute overdose reversal. The abstract does not explain the circumstances of those encounters [1]. EMS clinicians follow local protocols and medical direction on whether and how buprenorphine is carried.

Context

According to the abstract, prehospital buprenorphine pilot programs started in 2019. The study period opens the following year, when national data recorded 33 administrations. The authors note that opioid-related deaths remain at high rates [1].

What the records do not tell us

  • The packet contains only the PubMed abstract. The full methods, tables and any limitations section are not included [1].
  • The record does not define "documented improvement" or say how improvement and worsening were coded [1].
  • The record does not report which states or agencies contributed encounters beyond the South Atlantic regional rate, nor how many agencies had buprenorphine protocols [1].
  • The record does not say what happened to patients after the encounter, including whether they entered ongoing treatment [1].
  • The record does not list funding sources or author disclosures [1].
  • The dataset ends in 2023. The record does not describe use in 2024 or later [1].

Questions readers ask

How often do EMS crews give buprenorphine in the field?

A study of 2020-2023 National EMS Information System data found 2,180 encounters with buprenorphine administration out of 167,221,959 EMS encounters with patient contact. Annual counts rose from 33 in 2020 to 1,574 in 2023.

What dose of buprenorphine do paramedics give?

In the national data, the initial dose was 8 mg in 45% of encounters, 16 mg in 36% and 24 mg in 7%.

Do patients improve after prehospital buprenorphine?

The study reported documented improvement in 80% of administrations (n = 1,746). Four patients (0.2%) were documented as worse after the dose. The abstract does not define how improvement was recorded.

Which EMS providers administer prehospital buprenorphine?

Nearly all crews were advanced life support. Paramedic crews accounted for 53% of encounters and ALS community paramedic crews for 46%. About 72% of encounters were in urban areas.

Sources

  1. Chandran K et al. Prehospital Buprenorphine: A National Cross-Sectional Analysis. West J Emerg Med. PubMed record, November 13, 2026. — The western journal of emergency medicine (2026-11-13). pubmed.ncbi.nlm.nih.gov/43023763/
How this story was made Drafted by Mepa8's AI newsroom from the 1 record listed above and nothing else. Before publication a verification program confirmed that every number and quotation in the story appears in those records, that no passage was copied from them, and that every cited link opens. Editor: Ryan Bolden, EMS professional, who reviews published stories and handles corrections. Medical review pending. How we use AI · Report an error

This is news, not medical advice. EMS clinicians: follow your local protocols and medical direction.

Free alerts

Know about the next recall or outbreak the day it is posted.

One email when a story touches EMS equipment, medications or public health. Plus the free 6am briefing if you want it.

Send me